About Serin Formulations Private Limited
Data last updated:
Serin Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 21 December 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2001PTC038249. Its GSTIN is 36AAHCS7274A1ZC (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Vejju Venkateswara Rao (Managing Director) and Kodali Uma Shankar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 – 6 – 23/6/4/2 Sai Shakthi Bhavan Shivasakthi Nagar Moosapet, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.2 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹34.47 Lakh (net margin 4.8%) and EBITDA of ₹74.14 Lakh (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹65 Lakh and satisfied charges of ₹1.01 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website serinformulations.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address12 – 6 – 23/6/4/2 Sai Shakthi Bhavan Shivasakthi Nagar Moosapet, Hyderabad, Telangana, India – 500018
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Serin Formulations Private Limited
The main business activity of Serin Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Serin Formulations Private Limited FY 2025 filings available
Serin Formulations Private Limited reported revenue of ₹7.2 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Serin Formulations Private Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Serin Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹74.14 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34.47 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Serin Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Serin Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Serin Formulations Private Limited
Serin Formulations Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sivabalaji Silicates Private Limited | ₹7.24 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Hyderabad, Telangana, India |
| Minova Life Sciences Private Limited | ₹7.22 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Bengaluru, Karnataka, India |
| Endocard India Private Limited | ₹7.21 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Duckbill Drugs Pvt Ltd | ₹7.2 Cr (FY 2025) | •••• | •••• | 334.0% | •••• | Kolkata, West Bengal, India |
| Flourish Global Life Sciences Private Limited | ₹7.2 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Derabassi, Punjab, India |
| Serin Formulations Private Limited this company | ₹7.2 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Hyderabad, Telangana, India |
| Arham Ventures Private Limited | ₹7.2 Cr (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Avs Med Laboratories Private Limited | ₹7.18 Cr (FY 2024) | •••• | •••• | 59.0% | •••• | Chandauli, Uttar Pradesh, India |
| Bioartha Labs Private Limited | ₹7.18 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Bengaluru, Karnataka, India |
| SRG Healthcare Private Limited | ₹7.18 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Davanagere, Karnataka, India |
| Vatave Pharmacls India Private Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Serin Formulations by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Serin Formulations Private Limited
Serin Formulations Private Limited is audited by A.S.R.V.PRASAD AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A.S.R.V.PRASAD AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Serin Formulations Private Limited
Serin Formulations has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vannem Reddy Satti Raju | Director | 21 Dec 2001 | 24 Years 9 Months | Current |
| Kodali Uma Shankar | Whole-Time Director | 21 Dec 2001 | 24 Years 9 Months | Current |
| Vejju Venkateswara Rao Also directs: Amaze Pharmaceuticals Limited | Managing Director | 21 Dec 2001 | 24 Years 9 Months | Current |
| Naga Satyavathi Pasam | Director | 21 Dec 2001 | 24 Years 9 Months | Current |
Ownership and Shareholding of Serin Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Serin Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2022 | Bank of India | ₹65 Lakh | Open |
| 29 May 2019 | Hdfc Bank Limited | ₹75.68 Lakh | Satisfied |
| 23 May 2002 | Bank of India | ₹25 Lakh | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Serin Formulations Private Limited
Serin Formulations Private Limited has 2 court cases on record: 1 filed by Serin Formulations, 1 filed against it. 1 case is pending and 1 is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
| District courts | 1 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Court case (CRLP) | Filed against the company by Dar Laboratories Private Limited | Disposed |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Serin Formulations Private Limited
Serin Formulations Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 102 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Venkatadurga Polymers | •••• | •••• | •••• |
| Dots Lifescience Private Limited | •••• | •••• | •••• |
| Rexer Pharma Private Limited | •••• | •••• | •••• |
| H S Containers Private Limited | •••• | •••• | •••• |
| Sree Venkata Sai Packaging Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Serin Formulations Private Limited
Serin Formulations Private Limited has a workforce of 30 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Serin Formulations Private Limited
Serin Formulations has one previous CIN (Corporate Identification Number): U24231AP2001PTC038249. The current CIN is U24231TG2001PTC038249, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2001PTC038249 | Current |
| U24231AP2001PTC038249 | Previous |
Recent Activity on Serin Formulations Private Limited
Serin Formulations Private Limited has 5 board changes on record since 2001: 4 appointments and 1 cessation. The latest: Venkata Ramakishan Vummethala ceased to be Whole-Time Director on 30 Jun 2016.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Serin Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Serin Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Serin Formulations Private Limited
Serin Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCS7274A1ZC | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Serin Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Serin Formulations Private Limited
Serin Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 21 December 2001 (25+ years old) and is registered under CIN U24231TG2001PTC038249.
Serin Formulations reported revenue of ₹7.2 Cr for FY 2025 (down 2% YoY).
Serin Formulations has 4 current directors:
- Vejju Venkateswara Rao - Managing Director
- Kodali Uma Shankar - Whole-Time Director
- Vannem Reddy Satti Raju - Director
- Naga Satyavathi Pasam - Director
Serin Formulations reported a net profit of ₹34.47 Lakh (net margin 4.8%) and EBITDA of ₹74.14 Lakh (EBITDA margin 10.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Serin Formulations is 1% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Serin Formulations is 36AAHCS7274A1ZC, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Serin Formulations is U24231TG2001PTC038249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serin Formulations has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Serin Formulations was incorporated on 21 December 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Serin Formulations by revenue are Sivabalaji Silicates Private Limited, Minova Life Sciences Private Limited, Endocard India Private Limited, Duckbill Drugs Pvt Ltd, Flourish Global Life Sciences Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Venkata Ramakishan Vummethala ceased to be Whole-Time Director on 30 Jun 2016. Kodali Uma Shankar was appointed as Whole-Time Director on 21 Dec 2001. Naga Satyavathi Pasam was appointed as Director on 21 Dec 2001. Serin Formulations has 5 board changes on record in total.
Serin Formulations has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 102 overdue payments to 8 micro and small suppliers. The latest return was filed on 09 Jun 2019.